Table 2.
Pharmacological and other interventions that stimulate autophagy/lipophagy and reduced NAFLD development in mice.
Compound/intervention | Ref. |
---|---|
Caffeine | (111) |
Resveratrol | (112) |
Dioscin | (113) |
Capsaicin | (112) |
(-)-Epigallocatechin-3-gallate | (114) |
Quercetin | (115) |
Trehalose | (116) |
Exercise | (117) |
Fasting | (118) |
Intermittent fasting | (119) |
Caloric restriction | (118) |
Caloric restriction mimetics | (120) |
Rapamycin | (121) |
Carbamazepine | (121) |
TFEB agonists | (104, 105) |
Celecoxib | (107, 108) |
Thyroid hormone | (122) |
JNK inhibitor | (123) |